Patheon IncTSX: PTI

Patheon Announces Credit Agreement Amendments

· Issued by Patheon Inc via CNW
TORONTO, Oct. 16 /CNW/ - Patheon Inc. (TSX: PTI) today announced that it
has entered into an agreement with its lenders to amend certain financial
covenants under its North American loan facilities.
The amendment to the North American credit agreement establishes amended
financial covenants, including trailing 12-month debt-to-EBITDA covenants. The
amended covenants, to be satisfied monthly, cover a six-month period from
October 31, 2006 to March 31, 2007, by which time Patheon intends to have
implemented a long-term improvement to its capital structure.
"With this amendment in place, Patheon has the financial flexibility to
continue to operate our business effectively and in compliance with our loan
agreements. At the same time, we will continue to pursue strategic
alternatives that will serve the interests of our shareholders, clients, and
employees," said Mr. Riccardo Trecroce, Chief Executive Officer, Patheon Inc.
"We are making progress on the strategic review process announced last month,
and we intend to complete this process during the period covered by the
amendment to the credit agreement."
As at September 30, 2006, US$252.4 million was outstanding under the
North American loan facilities. As part of the amendment, the North American
revolving loan facility was reduced from US$75 million to US$60 million. As at
September 30, 2006, US$42.3 million was borrowed under this facility. The
maximum amount that may be borrowed under this facility from time to time is a
function of borrowing base calculations prescribed in the credit agreement,
and is typically less than US$60 million. The Company had US$49 million of
cash reserves as at September 30, 2006, and continues to be satisfied that it
has sufficient liquidity to carry on its business in the ordinary course.

About Patheon

Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing more than 5,900 people and serving a client base
of more than 200 pharmaceutical and biotechnology companies.

Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements which reflect
management's expectations regarding Patheon's future growth, results of
operations, performance (both operational and financial) and business
prospects and opportunities. Wherever possible, words such as "plans",
"expects" or "does not expect", "forecasts", "anticipates" or "does not
anticipate", "believes", "intends" and similar expressions or statements that
certain actions, events or results "may", "could", "would", "might" or "will"
be taken, occur or be achieved have been used to identify these forward-
looking statements. Although the forward-looking statements contained in this
press release reflect management's current assumptions based upon information
currently available to management and what management believes to be
reasonable assumptions, Patheon cannot be certain that actual results will be
consistent with these forward-looking statements. Forward-looking statements
necessarily involve significant known and unknown risks, assumptions and
uncertainties that may cause Patheon's actual results, performance, prospects
and opportunities in future periods to differ materially from those expressed
or implied by such forward-looking statements. These risks and uncertainties
include, among other things: the market demand for client products; dependence
on key clients; the ability to identify and secure new contracts; regulatory
matters, including compliance with pharmaceutical regulations; management of
expanded operations; international operations risks; currency risks;
competition; product liability claims; integration of new operations;
financing risks; and interest rate risks. Although Patheon has attempted to
identify important risks and factors that could cause actual actions, events
or results to differ materially from those described in the forward-looking
statements, there may be other factors and risks that cause actions, events or
results not to be as anticipated, estimated or intended. There can be no
assurance that forward-looking statements will prove to be accurate, and
results and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue reliance on
forward-looking statements. Except as otherwise stated, these forward-looking
statements are made as of the date of this press release and, except as
required by law, Patheon assumes no obligation to update or revise them to
reflect new events or circumstances.


Patheon Inc on 6ix

Story so far

Earlier from Patheon

Later from Patheon

All Patheon news releases